<DOC>
	<DOCNO>NCT01130922</DOCNO>
	<brief_summary>Roux-and-Y gastric bypass one common form bariatric surgery ; due reduction size stomach intestine , available surface area absorption oral drug strongly decrease . This may lead reduce bioavailability result reduced efficacy drug . However , literature information available impact bariatric surgery pharmacokinetics moxifloxacin . This protocol evaluate moxifloxacin plasma level , variability subject absolute bioavailability , oral administration 400 mg moxifloxacin healthy volunteer gastric bypass least 6 month ago stable body weight .</brief_summary>
	<brief_title>Pharmacokinetic Evaluation Moxifloxacin Administered Intravenously Orally Healthy Volunteers Who Have Had Gastric Bypass</brief_title>
	<detailed_description />
	<mesh_term>Body Weight</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Healthy volunteer gastric bypass least 6 month ago whose body weight change 5 % last 3 month Age 18 60 year old Able give inform consent Other form bariatric surgery ( Scopinaro Mason/Sleeve ) gastric bypass surgery Hypersensitivity moxifloxacin , quinolones excipients Pregnancy lactation Creatinine clearance &lt; 80 ml/min Transaminases &gt; 2x upper limit normal ( AST/ALT ) Impaired liver function ( Child Pugh C ) Fasting glycaemia &gt; 125mg/dl Epilepsy Patients history tendon disease/disorder ( especially Achilles tendon rupture ) relate quinolone treatment Patients follow heart disorder : Electrolyte disturbance , particularly uncorrected hypokalaemia Clinically relevant bradycardia Clinically relevant heart failure reduce leftventricular ejection fraction Previous history symptomatic arrhythmia Congenital document acquire QT prolongation concurrently use drug prolong QT interval : antiarrhythmic ( Classes IA III ) neuroleptic tricyclic antidepressant antimicrobial ( e.g . sparfloxacin , intravenous erythromycin , pentamidine , antimalarial particularly halofantrine ) antihistamine ( e.g . terfenadine , astemizole , mizolastine ) cisapride , intravenous vincamine , bepridil diphemanil No normal thyroid function All clinically significant disorder interfere study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Roux-and-Y gastric bypass surgery</keyword>
	<keyword>stable body weight</keyword>
</DOC>